Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Adv Biomed Res ; 12: 33, 2023.
Article in English | MEDLINE | ID: covidwho-2272433

ABSTRACT

The climatological parameters can be different in various geographical locations. Moreover, they have possible impacts on COVID-19 incidence. Therefore, the purpose of this systematic review article was to describe the effects of climatic variables on COVID-19 pandemic in different countries. Systematic literature search was performed in Scopus, ISI Web of Science, and PubMed databases using ("Climate" OR "Climate Change" OR "Global Warming" OR "Global Climate Change" OR "Meteorological Parameters" OR "Temperature" OR "Precipitation" OR "Relative Humidity" OR "Wind Speed" OR "Sunshine" OR "Climate Extremes" OR "Weather Extremes") AND ("COVID" OR "Coronavirus disease 2019" OR "COVID-19" OR "SARS-CoV-2" OR "Novel Coronavirus") keywords. From 5229 articles, 424 were screened and 149 were selected for further analysis. The relationship between meteorological parameters is variable in different geographical locations. The results indicate that among the climatic indicators, the temperature is the most significant factor that influences on COVID-19 pandemic in most countries. Some studies were proved that warm and wet climates can decrease COVID-19 incidence; however, the other studies represented that warm location can be a high risk of COVID-19 incidence. It could be suggested that all climate variables such as temperature, humidity, rainfall, precipitation, solar radiation, ultraviolet index, and wind speed could cause spread of COVID-19. Thus, it is recommended that future studies will survey the role of all meteorological variables and interaction between them on COVID-19 spread in specific small areas such as cities of each country and comparison between them.

2.
Viruses ; 14(6)2022 06 12.
Article in English | MEDLINE | ID: covidwho-1911625

ABSTRACT

Cyclospora cayetanensis infections remain one of the most common protozoan opportunistic causes of gastrointestinal diseases and diarrhea among people living with HIV and/or AIDS (PLWHA). This study was conducted to provide a summary of the evidence on the global burden of C. cayetanensis infection and associated risk factors among PLWHA. Scopus, PubMed, Science Direct, and EMBASE were searched up to February 2022. All original peer-reviewed original research articles were considered, including descriptive and cross-sectional studies describing C. cayetanensis in PLWHA. Incoherence and heterogeneity between studies were quantified by I index and Cochran's Q test. Publication and population bias were assessed with funnel plots and Egger's asymmetry regression test. All statistical analyses were performed using StatsDirect. The pooled prevalence of C. cayetanensis infection among PLWHA was 3.89% (95% CI, 2.62-5.40). The highest prevalence found in South America was 7.87% and the lowest in Asia 2.77%. In addition, the prevalence of C. cayetanensis was higher in PLWHA compared to healthy individuals. There was a relationship between a higher C. cayetanensis prevalence in PLWHA with a CD4 cell count below 200 cells/mL and people with diarrhea. The results show that PLWHA are more vulnerable to C. cayetanensis infection and emphasizes the need to implement the screening and prophylaxis tailored to the local context. Owing to the serious and significant clinical manifestations of the parasite, an early identification of seropositivity is recommended to initiate prophylaxis between PLWHA with a CD4 count ≤200 cells/mL and PLWHA who do not receive antiviral therapy.


Subject(s)
Acquired Immunodeficiency Syndrome , Cyclospora , Cyclosporiasis , Acquired Immunodeficiency Syndrome/complications , Cross-Sectional Studies , Cyclosporiasis/diagnosis , Cyclosporiasis/epidemiology , Cyclosporiasis/parasitology , Diarrhea/epidemiology , Humans , Risk Factors
3.
J Virol Methods ; 304: 114514, 2022 06.
Article in English | MEDLINE | ID: covidwho-1729973

ABSTRACT

By the emergence of SARS CoV-2 variants, many studies were developed to deal with it. The high transmissibility and mortality rate of some variants, in particular developing countries have caused the operation of simple diagnostic tests for genomic surveillance. In this study, we developed two assays of High Resolution Melting (HRM) and Probe-based RT-PCR as simple and inexpensive methods to identify the variants. We screened the mutations of del69-70, E484K, E484Q, D614G, L452R, and T478K in 100 cases from SARS-COV-2 positive patients in Kurdistan- Iran population. In general, the result of the two methods overlapped each other, nevertheless, we suggested HRM results be confirmed with a standard assay (Whole-Genome Sequencing). This work indicated that HRM as the rapid and inexpensive method could identify and categorize the variants of SARS CoV-2 and reduce the costs for carrying out sequencing.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/diagnosis , COVID-19/virology , Humans , Iran/epidemiology , Iraq/epidemiology , Mutation , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2/genetics , Spike Glycoprotein, Coronavirus/genetics
4.
J Am Med Inform Assoc ; 27(11): 1727-1731, 2020 11 01.
Article in English | MEDLINE | ID: covidwho-1024115

ABSTRACT

OBJECTIVES: The objective was to understand how people respond to coronavirus disease 2019 (COVID-19) screening chatbots. MATERIALS AND METHODS: We conducted an online experiment with 371 participants who viewed a COVID-19 screening session between a hotline agent (chatbot or human) and a user with mild or severe symptoms. RESULTS: The primary factor driving user response to screening hotlines (human or chatbot) is perceptions of the agent's ability. When ability is the same, users view chatbots no differently or more positively than human agents. The primary factor driving perceptions of ability is the user's trust in the hotline provider, with a slight negative bias against chatbots' ability. Asian individuals perceived higher ability and benevolence than did White individuals. CONCLUSIONS: Ensuring that COVID-19 screening chatbots provide high-quality service is critical but not sufficient for widespread adoption. The key is to emphasize the chatbot's ability and assure users that it delivers the same quality as human agents.


Subject(s)
Clinical Laboratory Techniques/methods , Coronavirus Infections/diagnosis , Medical Informatics Applications , Pandemics , Pneumonia, Viral/diagnosis , Telemedicine , Trust , COVID-19 , COVID-19 Testing , Communication , Female , Humans , Male , Text Messaging
SELECTION OF CITATIONS
SEARCH DETAIL